COURSE DESCRIPTION

A live panel of experts discuss an FDA approved non-immunosuppressive treatment for IgA nephropathy. The presentation will review recently published data followed by a panel discussion with Q&A.

The content and financial support of this webinar is provided by Travere Therapeutics. RPA does not endorse this webinar nor endorse or promote any specific commercial entities or products.

FEES

RPA Member
Complimentary

Non-Member
Complimentary

CREDIT HOURS

None available.

WHO WILL BENEFIT

Nephrology Practitioners

PRESENTERS

Speaker: Bruce Hendry, MD, PhD
European Lead Nephrology
Travere Therapeutics
Emeritus Professor of Medicine
King's College London

Panelist: Luis E. Velez, MD
South Texas Renal Care Group

Panelist: Jessica Coleman, MD
Nephrology and Hypertension Medical Associates